Concepedia

Eric L. Michelson

EL

Statistics

Publications

125

Citations

28.3K

H-Index

62

Active since

1977

Affiliations

AstraZeneca (United States)(Current)

Brigham and Women's Hospital

Duke Medical Center

University of Glasgow

McMaster University

Eric L. Michelson is an author at AstraZeneca (United States) specializing in medicine, cardiology, and cardiovascular disease.

Publications per year

1977–2016

125

Publications

125

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

Salim Yusuf, Marc A. Pfeffer, Karl Swedberg et al. · The Lancet · 2003 · 3K citations

Medicine, Cardiology, Internal Medicine +12

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

John J.V. McMurray, Jan Östergren, Karl Swedberg et al. · The Lancet · 2003 · 2.6K citations

Medicine, Cardiology, Pharmacology +15

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

Marc A. Pfeffer, Karl Swedberg, Christopher B. Granger et al. · The Lancet · 2003 · 1.9K citations

Pharmacy, Cardiology, Pharmacotherapy +11

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

Christopher B. Granger, John J.V. McMurray, Salim Yusuf et al. · The Lancet · 2003 · 1.7K citations

Medicine, Cardiology, Pharmacology +15

CHARM IN-VESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND REDUCED LEFT-VENTRICULAR SYSTOLIC FUNCTION TAKING ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS: THE CHARM-ADDED TRIAL

John J.V. McMurray, Jan Östergren, Karl Swedberg et al. · The Lancet · 2003 · 1K citations

Medicine, Cardiology, Pharmacology +13

1–5 of 125